THE ANTIVIRAL EFFECT OF KEISHI-NI-EPPI-ICHI-TO, A TRADITIONAL CHINESE HERBAL MEDICINE, ON INFLUENZA A(2)(H2N2) VIRUS-INFECTION IN MICE

被引:6
作者
BALL, MA
UTSUNOMIYA, T
IKEMOTO, K
KOBAYASHI, M
POLLARD, RB
SUZUKI, F
机构
[1] UNIV TEXAS,MED BRANCH,DEPT INTERNAL MED,GALVESTON,TX 77555
[2] SHRINERS BURN INST,GALVESTON,TX 77555
来源
EXPERIENTIA | 1994年 / 50卷 / 08期
关键词
TRADITIONAL CHINESE HERBAL MEDICINE; ANTIVIRAL EFFECT; INFLUENZA VIRUS; A MOUSE MODEL;
D O I
10.1007/BF01919381
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 [理学]; 0710 [生物学]; 09 [农学];
摘要
The antiviral effect of Keishi-ni-eppi-ichi-to (TJS-064), a traditional Chinese herbal medicine, was investigated in mice infected with influenza A(2)(H2N2) virus. When mice exposed to a 5 LD(50) dose of the virus were treated orally with a 70 mg/kg dose of TJS-064 1 day before and 1 day and 4 days after the infection, 100% survived over a 25-day experimental period. At the end of this period all the control mice, treated with saline alone, had died; their mean survival time in days (MSD) was 11.2 days. When mice infected with a 10 LD(50) dose of the virus were treated with TJS-064, the MSD was > 17.4 days and there was a 50% survival rate, while the control group had a MSD of 8.7 days and a 0% survival rate. No significant antiviral effect of TJS-064 was observed when the agent was administered orally to mice infected with a 100 LD(50) or larger dose of influenza virus. Pulmonary consolidations, virus titers in lung tissues and HAI titers in sera of infected mice treated with TJS-064 were all significantly lower than those of infected mice treated with saline. Interferon activities were detected in sera of mice treated with the agent at a dose of 100 mg/kg orally. Since viricidal and viristatic activities of the agent against influenza virus were not demonstrated, the antiviral effects of TJS-064 may be expressed through the host's antiviral functions including interferon production.
引用
收藏
页码:774 / 779
页数:6
相关论文
共 33 条
[1]
ASO H, 1989, J BIOL RESP MODIF, V8, P180
[2]
RESISTANCE OF FEMALE MICE TO VAGINAL INFECTION INDUCED BY HERPESVIRUS-HOMINIS TYPE 2 - EFFECTS OF IMMUNIZATION WITH MYCOBACTERIUM-BOVIS, INTRAVENOUS-INJECTION OF SPECIFIC HERPESVIRUS-HOMINIS TYPE 2 ANTISERUM, AND A COMBINATION OF THESE PROCEDURES [J].
BAKER, MB ;
LARSON, CL ;
USHIJIMA, RN ;
ANDERSON, FD .
INFECTION AND IMMUNITY, 1974, 10 (06) :1230-1234
[3]
BALL MA, 1993, 2ND INT C BIOL RESP, P73
[4]
CATE TR, 1986, ANTIVIRAL CHEMOTHERA, P78
[5]
ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE ( AMANTADINE ) [J].
DAVIES, WL ;
HOFFMANN, CE ;
PAULSHOCK, M ;
WOOD, TR ;
HAFF, RF ;
GRUNERT, RR ;
WATTS, JC ;
HERMANN, EC ;
NEUMAYER, EM ;
MCGAHEN, JW .
SCIENCE, 1964, 144 (362) :862-&
[6]
ANTIVIRAL CHEMOTHERAPY AND CHEMOPROPHYLAXIS [J].
DOLIN, R .
SCIENCE, 1985, 227 (4692) :1296-1303
[7]
PROTECTIVE EFFECT OF BIOLOGICAL RESPONSE MODIFIERS ON MURINE CYTOMEGALOVIRUS-INFECTION [J].
EBIHARA, K ;
MINAMISHIMA, Y .
JOURNAL OF VIROLOGY, 1984, 51 (01) :117-122
[8]
FUJII H, 1989, IMMUNOL LETT, V21, P127
[9]
INTERFERON-INDUCING ACTIVITY OF AN IMMUNOTHERAPEUTIC ANTI-CANCER AGENT, SSM, PREPARED FROM MYCOBACTERIUM-TUBERCULOSIS STRAIN AOYAMA-B [J].
HAYASHI, Y ;
EBINA, T ;
SUZUKI, F ;
ISHIDA, N .
MICROBIOLOGY AND IMMUNOLOGY, 1981, 25 (03) :305-316
[10]
Hosoya E., 1988, RECENT ADV PHARM KAM